Evidence map›Paper›PMID 19906643›Full record

ArticleThe Journal of biological chemistry2010

Characterization of the East Asian variant of aldehyde dehydrogenase-2: bioactivation of nitroglycerin and effects of Alda-1.

Matteo Beretta, Antonius C F Gorren, M Verena Wenzl, Robert Weis, Michael Russwurm, Doris Koesling, Kurt Schmidt, Bernd Mayer

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Catalytic contribution of threonine 244 in human ALDH2.Chemico-biological interactions · 2013
    Article
  16. Article
  17. Article
  18. Nitroglycerin use in myocardial infarction patients.Circulation journal : official journal of the Japanese Circulation Society · 2012
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Matteo BerettaDepartment of Pharmacology and Toxicology, Karl-Franzens-Universität Graz, 8010 Graz, Austria
Antonius C F Gorren
M Verena Wenzl
Robert Weis
Michael Russwurm
Doris Koesling
Kurt Schmidt
Bernd Mayer
University of Graz · ATRuhr University Bochum · DE

Funding

Austrian Science Fund FWF P 20669Austrian Science Fund FWF P 21693Austrian Science Fund FWF W 901
6 · The paper itself

Abstract

The East Asian variant of mitochondrial aldehyde dehydrogenase (ALDH2) exhibits significantly reduced dehydrogenase, esterase, and nitroglycerin (GTN) denitrating activities. The small molecule Alda-1 was reported to partly restore low acetaldehyde dehydrogenase activity of this variant. In the present study we compared the wild type enzyme (ALDH2*1) with the Asian variant (ALDH2*2) regarding GTN bioactivation and the effects of Alda-1. Alda-1 increased acetaldehyde oxidation by ALDH2*1 and ALDH2*2 approximately 1.5- and 6-fold, respectively, and stimulated the esterase activities of both enzymes to similar extent as the coenzyme NAD. The effect of NAD was biphasic with pronounced inhibition occurring at > or = 5 mM. In the presence of 1 mM NAD, Alda-1 stimulated ALDH2*2-catalyzed ester hydrolysis 73-fold, whereas the NAD-stimulated activity of ALDH2*1 was inhibited because of 20-fold increased inhibitory potency of NAD in the presence of the drug. Although ALDH2*2 exhibited 7-fold lower GTN denitrating activity and GTN affinity than ALDH2*1, the rate of nitric oxide formation was only reduced 2-fold, and soluble guanylate cyclase (sGC) activation was more pronounced than with wild type ALDH2 at saturating GTN. Alda-1 caused slight inhibition of GTN denitration and did not increase GTN-induced sGC activation in the presence of either variant. The present results indicate that Alda-1 stimulates established ALDH2 activities by improving NAD binding but does not improve the GTN binding affinity of the Asian variant. In addition, our data revealed an unexpected discrepancy between GTN reductase activity and sGC activation, suggesting that GTN denitration and bioactivation may reflect independent pathways of ALDH2-catalyzed GTN biotransformation.

Indexed as

Genetic VariationAcetaldehydeAldehyde DehydrogenaseAldehyde Dehydrogenase, MitochondrialAnimalsAsia, EasternBenzamidesBenzodioxolesCattleEnzyme ActivationGuanylate CyclaseHumansMitochondrial ProteinsNADNitric OxideNitroglycerinAcetaldehydeAldehyde DehydrogenaseAldehyde Dehydrogenase, MitochondrialALDH2 protein, humanBenzamidesBenzodioxolesGuanylate CyclaseMitochondrial ProteinsN-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamideNADNitric OxideNitroglycerinVasodilator Agents

Identifiers

PMID19906643
PMCPMC2801295
OpenAlexW2025289525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.